Skip to main content

Articles

Page 47 of 61

  1. The presence of cardiovascular disease (CVD) in Type 1 diabetes largely impairs life expectancy. Hyperglycemia leading to an increase in oxidative stress is considered to be the key pathophysiological factor o...

    Authors: Oliver Schnell, Francesco Cappuccio, Stefano Genovese, Eberhard Standl, Paul Valensi and Antonio Ceriello
    Citation: Cardiovascular Diabetology 2013 12:156
  2. Intima-media thickness (IMT) is a validated marker of preclinical atherosclerosis and a predictor of cardiovascular events.

    Authors: Salvatore Novo, Angelica Peritore, Rosaria Linda Trovato, Francesco Paolo Guarneri, Daniela Di Lisi, Ida Muratori and Giuseppina Novo
    Citation: Cardiovascular Diabetology 2013 12:155
  3. The dipeptidyl peptidase-4 (DPP-4) inhibitors Sitagliptin and Vildagliptin lower blood glucose by augmenting endogenous levels of glucagon-like peptide-1 (GLP-1), an incretin which also confers cardioprotectio...

    Authors: Derek J Hausenloy, Hannah J Whittington, Abigail M Wynne, Shah S Begum, Louise Theodorou, Niels Riksen, Mihaela M Mocanu and Derek M Yellon
    Citation: Cardiovascular Diabetology 2013 12:154
  4. Detection of early vascular changes prior to clinical manifestations of atherosclerosis, such as increased arterial carotid intima-media thickness (CIMT) and impaired endothelial function is of paramount impor...

    Authors: Sema Ciftci Dogansen, Aysen Helvaci, Mine Adas and Suzan Deniz Onal
    Citation: Cardiovascular Diabetology 2013 12:153
  5. The combination of systemic arterial hypertension and diabetes mellitus (DM) induces greater cardiac remodeling than either condition alone. However, this association has been poorly addressed in senescent rat...

    Authors: Camila Moreno Rosa, Natasha Priscilla Xavier, Dijon Henrique Campos, Ana Angélica Henrique Fernandes, Marcelo Diarcadia Mariano Cezar, Paula Felippe Martinez, Antonio Carlos Cicogna, Camila Gimenes, Rodrigo Gimenes, Marina Politi Okoshi and Katashi Okoshi
    Citation: Cardiovascular Diabetology 2013 12:152
  6. Activation of the renin-angiotensin system (RAS) plays a critical role in the pathophysiology of myocardial infarction (MI) and the development of heart failure. Both angiotensin-converting enzyme 2 (ACE2) and...

    Authors: Wei Liu, Xinmin Zhou, Fenglei Yu, Jianguo Hu and Wen Hu
    Citation: Cardiovascular Diabetology 2013 12:151
  7. Activin A released from epicardial adipose tissue has been linked to contractile dysfunction and insulin resistance in cardiomyocytes. This study investigated the role of activin A in clinical diabetic cardiom...

    Authors: Weena JY Chen, Sabrina Greulich, Rutger W van der Meer, Luuk J Rijzewijk, Hildo J Lamb, Albert de Roos, Johannes WA Smit, Johannes A Romijn, Johannes B Ruige, Adriaan A Lammertsma, Mark Lubberink, Michaela Diamant and D Margriet Ouwens
    Citation: Cardiovascular Diabetology 2013 12:150
  8. Advanced glycation endproducts (AGEs) may play a role in the development of coronary artery calcification (CAC) in type 1 diabetes (T1DM). We studied plasma AGEs in association with T1DM and CAC, and whether o...

    Authors: Marcelle GA van Eupen, Miranda T Schram, Helen M Colhoun, Jean LJM Scheijen, Coen DA Stehouwer and Casper G Schalkwijk
    Citation: Cardiovascular Diabetology 2013 12:149
  9. Glucagon-like peptide-1 (GLP-1) and its mimetics reduce infarct size in the setting of acute myocardial ischemia/reperfusion (I/R) injury. However, the short serum half-life of GLP-1 and its mimetics may limit...

    Authors: Weike Bao, Lucy J Holt, Rob D Prince, Gavin X Jones, Karpagam Aravindhan, Mathew Szapacs, April M Barbour, Larry J Jolivette, John J Lepore, Robert N Willette, Elena DeAngelis and Beat M Jucker
    Citation: Cardiovascular Diabetology 2013 12:148
  10. The high glucose-induced proliferation of vascular smooth muscle cells (VSMCs) plays an important role in the development of diabetic vascular diseases. In a previous study, we confirmed that Interferon regula...

    Authors: Xi Zhang, Long Liu, Chao Chen, Ya-Li Chi, Xiang-Qun Yang, Yan Xu, Xiao-Tong Li, Shi-Lei Guo, Shao-Hu Xiong, Man-Ru Shen, Yu Sun, Chuan-Sen Zhang and Kai-Meng Hu
    Citation: Cardiovascular Diabetology 2013 12:147
  11. The prevalence of diabetes in China is increasing rapidly. However, scarce data are available on serum electrolyte levels in Chinese adults with diabetes, especially in those with cardiovascular complications....

    Authors: Shenqi Wang, Xuhong Hou, Yu Liu, Huijuan Lu, Li Wei, Yuqian Bao and Weiping Jia
    Citation: Cardiovascular Diabetology 2013 12:146
  12. Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthesis inhibitor, and insulin resistance (IR) have been implicated in atherogenesis. Our aim was to estimate relations between ADMA, the magnit...

    Authors: Olga Kruszelnicka, Andrzej Surdacki and Alain Golay
    Citation: Cardiovascular Diabetology 2013 12:145
  13. Patients with type 2 diabetes mellitus (T2DM) present subclinical left ventricular systolic and/or diastolic dysfunction (LVD). Dipeptidyl peptidase-4 (DPP4) inactivates peptides that possess cardioprotective ...

    Authors: Susana Ravassa, Joaquín Barba, Isabel Coma-Canella, Ana Huerta, Begoña López, Arantxa González and Javier Díez
    Citation: Cardiovascular Diabetology 2013 12:143
  14. Endothelial dysfunction precedes pathogenesis of vascular complications in diabetes. In recent years, the mechanisms of endothelial dysfunction were investigated to outline strategies for its treatment. Howeve...

    Authors: Hemang Patel, Juan Chen, Kumuda C Das and Mahendra Kavdia
    Citation: Cardiovascular Diabetology 2013 12:142
  15. Accumulation of advanced glycation end products (AGEs) in the vasculature triggers a series of morphological and functional changes contributing to endothelial hyperpermeability. The reorganisation and redistr...

    Authors: Zhenyu Li, Qiaoqing Zhong, Tianlun Yang, Xiumei Xie and Meifang Chen
    Citation: Cardiovascular Diabetology 2013 12:141
  16. It is a matter of debate whether metabolic syndrome (MS) improves cardiovascular risk prediction beyond the risk associated with its individual components. The present study examined the association of MS scor...

    Authors: Jong-Youn Kim, Eui-Young Choi, Hee-Sun Mun, Pil-Ki Min, Young-Won Yoon, Byoung Kwon Lee, Bum-Kee Hong, Se-Joong Rim and Hyuck Moon Kwon
    Citation: Cardiovascular Diabetology 2013 12:140
  17. Development of a cardiomyopathy in diabetes mellitus is independent of traditional risk factors, with no clinical trials targeting specific therapeutic interventions. Myocardial fibrosis is one of the key mech...

    Authors: Melissa Leung, Vincent W Wong, Stephane Heritier, Anastasia S Mihailidou and Dominic Y Leung
    Citation: Cardiovascular Diabetology 2013 12:139
  18. Dyslipidemia, a major risk factor for cardiovascular disease is a common finding in patients with type 2 diabetes and among women with gestational diabetes. Elevated levels of lipoprotein(a) [Lp(a)] are linked...

    Authors: Jelena Todoric, Ammon Handisurya, Karoline Leitner, Juergen Harreiter, Gregor Hoermann and Alexandra Kautzky-Willer
    Citation: Cardiovascular Diabetology 2013 12:138
  19. A relationship between plasma adiponectin level and a number of metabolic conditions, including insulin resistance, obesity, and type 2 diabetes, has been reported. This study aimed to assess whether urinary a...

    Authors: Won Seon Jeon, Ji Woo Park, Namseok Lee, Se Eun Park, Eun Jung Rhee, Won Young Lee, Ki Won Oh, Sung Woo Park, Cheol-Young Park and Byung-Soo Youn
    Citation: Cardiovascular Diabetology 2013 12:137
  20. To study the pathogenesis of diabetic cardiomyopathy, reliable animal models of type 2 diabetes are required. Physiologically relevant rodent models are needed, which not only replicate the human pathology but...

    Authors: Latt S Mansor, Eileen R Gonzalez, Mark A Cole, Damian J Tyler, Jessica H Beeson, Kieran Clarke, Carolyn A Carr and Lisa C Heather
    Citation: Cardiovascular Diabetology 2013 12:136
  21. Increased levels of the sugar metabolite methylglyoxal (MG) in vivo were shown to participate in the pathophysiology of vascular complications in diabetes. Alterations of endothelial nitric oxide synthase (eNOS) ...

    Authors: Yang Su, Syed M Qadri, Lingyun Wu and Lixin Liu
    Citation: Cardiovascular Diabetology 2013 12:134
  22. Large body of evidences accumulated in clinical and epidemiological studies indicate that hearts of diabetic subjects are more sensitive to ischemia reperfusion injury (IRI), which results in a higher rate of ...

    Authors: Haobo Li, Zipeng Liu, Junwen Wang, Gordon T Wong, Chi-Wai Cheung, Liangqing Zhang, Can Chen, Zhengyuan Xia and Michael G Irwin
    Citation: Cardiovascular Diabetology 2013 12:133
  23. Mitochondrial aldehyde dehydrogenase 2 (ALDH2) detoxifies reactive aldehydes in the micro- and macrovasculature. These substrates, including methylglyoxal and 4-hydroxynonenal formed from glucose and lipids, c...

    Authors: Kazunori Morita, Junji Saruwatari, Haruna Miyagawa, Yoshihiro Uchiyashiki, Kentaro Oniki, Misaki Sakata, Ayami Kajiwara, Akira Yoshida, Hideaki Jinnouchi and Kazuko Nakagawa
    Citation: Cardiovascular Diabetology 2013 12:132
  24. The Cardiovascular Risk Evaluation in people with type 2 Diabetes on Insulin Therapy (CREDIT) study is an international, multicenter, observational study designed to assess metabolic parameters and cardiovascu...

    Authors: Ryuzo Kawamori, Koichi Node, Toshiaki Hanafusa, Yoshihito Atsumi, Yusuke Naito and Yoshitomo Oka
    Citation: Cardiovascular Diabetology 2013 12:131
  25. Sulfonylureas (SUs) are commonly used in the treatment of type 2 diabetes (T2DM), usually as second-line treatment after the failure of metformin. However, SUs are associated with poor durability, hypoglycemia...

    Authors: Martin Ridderstråle, Robbyna Svaerd, Cordula Zeller, Gabriel Kim, Hans J Woerle and Uli C Broedl
    Citation: Cardiovascular Diabetology 2013 12:129
  26. This study aimed to evaluate the efficacy of mesenchymal stem cell (MSC) transplantation to mitigate abnormalities in cardiac-specific and systemic metabolism mediated by a combination of a myocardial infarcti...

    Authors: Curtis C Hughey, Lianli Ma, Freyja D James, Deanna P Bracy, Zhizhang Wang, David H Wasserman, Jeffrey N Rottman, Dustin S Hittel and Jane Shearer
    Citation: Cardiovascular Diabetology 2013 12:128
  27. Symptoms of heart failure with preserved left ventricular systolic function are common among patients undergoing peritoneal dialysis (PD). Epicardial fat (EpF) is an ectopic fat depot with possible paracrine o...

    Authors: Heng-Hsu Lin, Jen-Kuang Lee, Chung-Yi Yang, Yu-Chung Lien, Jenq-Wen Huang and Cho-Kai Wu
    Citation: Cardiovascular Diabetology 2013 12:127
  28. Novel and robust cardiovascular (CV) markers are needed to improve CV morbidity and mortality risk prediction in type 2 diabetes (T2D). We assessed the long term predictive value of 4 novel CV risk markers for...

    Authors: Anne Pernille Ofstad, Lars Gullestad, Elsa Orvik, Svend Aakhus, Knut Endresen, Thor Ueland, Pål Aukrust, Morten W Fagerland, Kåre I Birkeland and Odd Erik Johansen
    Citation: Cardiovascular Diabetology 2013 12:126
  29. Advanced glycation end products (AGEs) and receptor RAGE interaction play a role in diabetic vascular complications. Inhibition of dipeptidyl peptidase-4 (DPP-4) is a potential therapeutic target for type 2 di...

    Authors: Yuji Ishibashi, Takanori Matsui, Sayaka Maeda, Yuichiro Higashimoto and Sho-ichi Yamagishi
    Citation: Cardiovascular Diabetology 2013 12:125
  30. Expression and activity of the fibroblast growth factor (FGF) 21 hormone-like protein are associated with development of several metabolic disorders. This study was designed to investigate whether serum FGF21 ...

    Authors: Yun Shen, Xiaojing Ma, Jian Zhou, Xiaoping Pan, Yaping Hao, Mi Zhou, Zhigang Lu, Meifang Gao, Yuqian Bao and Weiping Jia
    Citation: Cardiovascular Diabetology 2013 12:124
  31. Intracellular calcium (Ca2+) coordinates the cardiac contraction cycle and is dysregulated in diabetic cardiomyopathy. Treatment with triethylenetetramine (TETA), a divalent-copper-selective chelator, improves ca...

    Authors: Lin Zhang, Marie-Louise Ward, Anthony RJ Phillips, Shaoping Zhang, John Kennedy, Bernard Barry, Mark B Cannell and Garth JS Cooper
    Citation: Cardiovascular Diabetology 2013 12:123
  32. Authors: Joris van Ark, Hans-Peter Hammes, Marcory CRF van Dijk, Chris PH Lexis, Iwan CC van der Horst, Clark J Zeebregts, Marc G Vervloet, Bruce HR Wolffenbuttel, Harry van Goor and Jan-Luuk Hillebrands
    Citation: Cardiovascular Diabetology 2013 12:120

    The original article was published in Cardiovascular Diabetology 2013 12:116

  33. Non-invasive measurements of 24 hour ambulatory central aortic systolic pressure (24 h-CASP) and central pulse pressure (24 h-CPP) are now feasible. We evaluate the relationship between 24 h central blood pres...

    Authors: Simone Theilade, Maria Lajer, Tine Willum Hansen, Christel Joergensen, Frederik Persson, Gudbjörg Andrésdottir, Henrik Reinhard, Stine Elkjær Nielsen, Peter Lacy, Bryan Williams and Peter Rossing
    Citation: Cardiovascular Diabetology 2013 12:122
  34. Cardiovascular risk stratification of asymptomatic diabetic patients is important and remains a difficult clinical problem. Our aim was to test the hypothesis that coronary flow reserve (CFR) assessed by nonin...

    Authors: Takayuki Kawata, Masao Daimon, Rei Hasegawa, Tomohiko Toyoda, Tai Sekine, Toshiharu Himi, Daigaku Uchida, Sakiko Miyazaki, Kuniaki Hirose, Ryoko Ichikawa, Masaki Maruyama, Hiromasa Suzuki and Hiroyuki Daida
    Citation: Cardiovascular Diabetology 2013 12:121
  35. Nicotinamide phosphoribosyltransferase (NAMPT) is the limiting enzyme in one of pathways of synthesis of Nicotinamide Adenine Dinucleotide, a redox coenzyme. NAMPT is considered as an insulin-mimetic factor an...

    Authors: Pedro Saddi-Rosa, Carolina Soares Oliveira, Felipe Crispim, Fernando MA Giuffrida, Valter Correia de Lima, José Gilberto Vieira, Alessandro Doria, Gilberto Velho and André Fernandes Reis
    Citation: Cardiovascular Diabetology 2013 12:119
  36. Limitations of the currently recommended stepwise treatment pathway for type 2 diabetes mellitus (T2DM), especially the failure of monotherapies to maintain good glycemic control, have prompted use of early, m...

    Authors: Li-Nong Ji, Chang-Yu Pan, Ju-Ming Lu, Hong Li, Qiang Li, Qi-Fu Li, Yong-De Peng, Hao-Ming Tian, Chen Yao, Zhi-Gang Zhao, Ru-Ya Zhang, Xiang-Ling Wang and Lei Wang
    Citation: Cardiovascular Diabetology 2013 12:118
  37. GLP-1 is an incretine hormone which gets secreted from intestinal L-cells in response to nutritional stimuli leading to pancreatic insulin secretion and suppression of glucagon release. GLP-1 further inhibits ...

    Authors: Katja Piotrowski, Melanie Becker, Julia Zugwurst, Ingeborg Biller-Friedmann, Gerald Spoettl, Martin Greif, Alexander W Leber, Alexander Becker, Rüdiger P Laubender, Corinna Lebherz, Burkhard Goeke, Nikolaus Marx, Klaus G Parhofer and Michael Lehrke
    Citation: Cardiovascular Diabetology 2013 12:117
  38. Diabetes is associated with a high incidence of macrovascular disease (MVD), including peripheral and coronary artery disease. Circulating soluble-Klotho (sKlotho) is produced in the kidney and is a putative a...

    Authors: Joris van Ark, Hans-Peter Hammes, Marcory C R F van Dijk, Marc G Vervloet, Bruce H R Wolffenbuttel, Harry van Goor and Jan-Luuk Hillebrands
    Citation: Cardiovascular Diabetology 2013 12:116

    The Erratum to this article has been published in Cardiovascular Diabetology 2013 12:120

  39. We used Laser Doppler Fluximetry (LDF) to define "normal" endothelial function in a large cohort of healthy children and adolescents and to evaluate skin microcirculation in paediatric patients with type 1 dia...

    Authors: Mirjam Heimhalt-El Hamriti, Corinna Schreiver, Anja Noerenberg, Julia Scheffler, Ulrike Jacoby, Dieter Haffner and Dagmar-C Fischer
    Citation: Cardiovascular Diabetology 2013 12:115
  40. Cardiac nestin(+) cells exhibit properties of a neural progenitor/stem cell population characterized by the de novo synthesis of neurofilament-M in response to ischemic injury and 6-hydroxydopamine administration...

    Authors: Andreanne Chabot, Marc-Andre Meus, Vanessa Hertig, Natacha Duquette and Angelino Calderone
    Citation: Cardiovascular Diabetology 2013 12:114
  41. Little or no research has determined the effect of vitamin D3 supplementation in conjunction with pharmacological and non-pharmacological approaches in the diabetes mellitus type 2 (DMT2) patients. The objecti...

    Authors: Khalid M Alkharfy, Nasser M Al-Daghri, Shaun B Sabico, Abdulaziz Al-Othman, Osama Moharram, Majed S Alokail, Yousef Al-Saleh, Sudhesh Kumar and George P Chrousos
    Citation: Cardiovascular Diabetology 2013 12:113
  42. Qualitative alterations of lipoproteins underlie the high incidence of atherosclerosis in diabetes. The objective of this study was to assess the impact of low-density lipoprotein (LDL) subfraction phenotype o...

    Authors: Jose Luis Sánchez-Quesada, Irene Vinagre, Elena De Juan-Franco, Juan Sánchez-Hernández, Rosa Bonet-Marques, Francisco Blanco-Vaca, Jordi Ordóñez-Llanos and Antonio Pérez
    Citation: Cardiovascular Diabetology 2013 12:112
  43. Activation of RhoA/Rho-kinase (ROCK) is increasingly implicated in acute vasospasm and chronic vasoconstriction in major organ systems. Therefore we aimed to ascertain whether an increase in ROCK activity play...

    Authors: James T Pearson, Mathew J Jenkins, Amanda J Edgley, Takashi Sonobe, Mandar Joshi, Mark T Waddingham, Yutaka Fujii, Daryl O Schwenke, Hirotsugu Tsuchimochi, Misa Yoshimoto, Keiji Umetani, Darren J Kelly and Mikiyasu Shirai
    Citation: Cardiovascular Diabetology 2013 12:111
  44. Low-grade albuminuria is associated with cardiovascular risk factors and mortality. Our aim was to investigate the association between low-grade albuminuria and carotid atherosclerotic lesions in community-bas...

    Authors: Mei-Fang Li, Yin-Fang Tu, Lian-Xi Li, Jun-Xi Lu, Xue-Hong Dong, Li-Bo Yu, Rong Zhang, Yu-Qian Bao, Wei-Ping Jia and Ren-Ming Hu
    Citation: Cardiovascular Diabetology 2013 12:110
  45. Left ventricular hypertrophy has multiple aetiologies including diabetes and genetic factors. We aimed to identify genetic variants predicting left ventricular hypertrophy in diabetic individuals.

    Authors: Helen M Parry, Louise A Donnelly, Natalie Van Zuydam, Alexander SF Doney, Douglas HJ Elder, Andrew D Morris, Alan D Struthers, Colin NA Palmer and Chim C Lang
    Citation: Cardiovascular Diabetology 2013 12:109
  46. Circulatory and tissue renin-angiotensin systems (RAS) play a central role in cardiovascular (CV) and renal pathophysiology, making RAS inhibition a logical therapeutic approach in the prevention of CV and ren...

    Authors: Samir G Mallat
    Citation: Cardiovascular Diabetology 2013 12:108
  47. The arterial system in diabetic patients is characterized by generalized non-atherosclerotic alterations in the vascular extracellular matrix causing increased arterial stiffness compared with subjects without...

    Authors: Esben Laugesen, Pernille Høyem, Jens Sandahl Christiansen, Søren Tang Knudsen, Klavs Würgler Hansen, W Scott Argraves, Troels Krarup Hansen, Per Løgstrup Poulsen and Lars Melholt Rasmussen
    Citation: Cardiovascular Diabetology 2013 12:107

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions